Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Carbetocin (Duratocin) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Carbetocin (Duratocin) market segmented into
Tablets
Injection
Based on the end-use, the global Carbetocin (Duratocin) market classified into
Oxytocic
Antihemorrhagic
Uterotonic
Based on geography, the global Carbetocin (Duratocin) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
Acinopeptide Co., Ltd.
BOC Sciences
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CARBETOCIN (DURATOCIN) INDUSTRY
2.1 Summary about Carbetocin (Duratocin) Industry
2.2 Carbetocin (Duratocin) Market Trends
2.2.1 Carbetocin (Duratocin) Production & Consumption Trends
2.2.2 Carbetocin (Duratocin) Demand Structure Trends
2.3 Carbetocin (Duratocin) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tablets
4.2.2 Injection
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oxytocic
4.3.2 Antihemorrhagic
4.3.3 Uterotonic
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tablets
5.2.2 Injection
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oxytocic
5.3.2 Antihemorrhagic
5.3.3 Uterotonic
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tablets
6.2.2 Injection
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oxytocic
6.3.2 Antihemorrhagic
6.3.3 Uterotonic
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tablets
7.2.2 Injection
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oxytocic
7.3.2 Antihemorrhagic
7.3.3 Uterotonic
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tablets
8.2.2 Injection
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oxytocic
8.3.2 Antihemorrhagic
8.3.3 Uterotonic
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tablets
9.2.2 Injection
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oxytocic
9.3.2 Antihemorrhagic
9.3.3 Uterotonic
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Beacon Pharmaceuticals Limited
10.1.2 Ferring Inc.
10.1.3 Polypeptide Laboraries France
10.1.4 Chemos GmbH & Co. KG
10.1.5 Hangzhou Dayangchem Co. Ltd.
10.1.6 Acinopeptide Co., Ltd.
10.1.7 Bachem AG
10.1.8 Clearsynth Canada INC.
10.1.9 Leap Labchem Co., Ltd
10.1.10 Chemieliva Pharmaceutical Co., Ltd.
10.1.11 Acinopeptide Co., Ltd.
10.1.12 BOC Sciences
10.2 Carbetocin (Duratocin) Sales Date of Major Players (2017-2020e)
10.2.1 Beacon Pharmaceuticals Limited
10.2.2 Ferring Inc.
10.2.3 Polypeptide Laboraries France
10.2.4 Chemos GmbH & Co. KG
10.2.5 Hangzhou Dayangchem Co. Ltd.
10.2.6 Acinopeptide Co., Ltd.
10.2.7 Bachem AG
10.2.8 Clearsynth Canada INC.
10.2.9 Leap Labchem Co., Ltd
10.2.10 Chemieliva Pharmaceutical Co., Ltd.
10.2.11 Acinopeptide Co., Ltd.
10.2.12 BOC Sciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Carbetocin (Duratocin) Product Type Overview
Table Carbetocin (Duratocin) Product Type Market Share List
Table Carbetocin (Duratocin) Product Type of Major Players
Table Brief Introduction of Beacon Pharmaceuticals Limited
Table Brief Introduction of Ferring Inc.
Table Brief Introduction of Polypeptide Laboraries France
Table Brief Introduction of Chemos GmbH & Co. KG
Table Brief Introduction of Hangzhou Dayangchem Co. Ltd.
Table Brief Introduction of Acinopeptide Co., Ltd.
Table Brief Introduction of Bachem AG
Table Brief Introduction of Clearsynth Canada INC.
Table Brief Introduction of Leap Labchem Co., Ltd
Table Brief Introduction of Chemieliva Pharmaceutical Co., Ltd.
Table Brief Introduction of Acinopeptide Co., Ltd.
Table Brief Introduction of BOC Sciences
Table Products & Services of Beacon Pharmaceuticals Limited
Table Products & Services of Ferring Inc.
Table Products & Services of Polypeptide Laboraries France
Table Products & Services of Chemos GmbH & Co. KG
Table Products & Services of Hangzhou Dayangchem Co. Ltd.
Table Products & Services of Acinopeptide Co., Ltd.
Table Products & Services of Bachem AG
Table Products & Services of Clearsynth Canada INC.
Table Products & Services of Leap Labchem Co., Ltd
Table Products & Services of Chemieliva Pharmaceutical Co., Ltd.
Table Products & Services of Acinopeptide Co., Ltd.
Table Products & Services of BOC Sciences
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Carbetocin (Duratocin) Market Forecast (Million USD) by Region 2021f-2026f
Table Global Carbetocin (Duratocin) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Carbetocin (Duratocin) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Carbetocin (Duratocin) Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Carbetocin (Duratocin) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Carbetocin (Duratocin) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Carbetocin (Duratocin) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Carbetocin (Duratocin) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Carbetocin (Duratocin) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Carbetocin (Duratocin) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Carbetocin (Duratocin) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oxytocic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemorrhagic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Uterotonic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Beacon Pharmaceuticals Limited 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Ferring Inc. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Polypeptide Laboraries France 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Chemos GmbH & Co. KG 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Hangzhou Dayangchem Co. Ltd. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Acinopeptide Co., Ltd. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Bachem AG 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Clearsynth Canada INC. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Leap Labchem Co., Ltd 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Chemieliva Pharmaceutical Co., Ltd. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of Acinopeptide Co., Ltd. 2017-2020e
Figure Carbetocin (Duratocin) Sales Revenue (Million USD) of BOC Sciences 2017-2020e